Andrew Charles Von Eschenbach

Andrew Charles Von Eschenbach appears in our data through filings on Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) shares, published by SEDI. We count 3 filings; the first trade dates from 29 October 2018 and the latest from 12 May 2022.

No open-market sale appears; the market trades are 2 purchases worth €38k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2022, the count stands at 2 purchases and no sales.

The latest filing, published on 17 May 2022, reports an open-market purchase of €13k in Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). Typically, a trade is published a median of 5 days after it takes place. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.